483 Roundup: FDA Raps Four Firms for Quality Deficiencies By PacConAdmin | November 1, 2021 Cleaning and maintenance lapses feature among the deficiencies observed by FDA investigators during inspections of four drug facilities. Source: Drug GMP Report Posted in Drug GMP Report